Literature DB >> 13898067

Studies on the relationship of 5-hydroxytryptamine and the enterochromaffin cell to anaphylactic shock in mice.

M D GERSHON, L L ROSS.   

Abstract

Protection against anaphylactic shock in mice by reserpine has been shown to be a delayed phenomenon, probably not dependent upon a direct effect of reserpine. The release and depletion of catechol amines by reserpine show little likelihood of being responsible for protection because these substances are in themselves protective against anaphylactic shock, while beta-TM 10, a drug which interferes with their release is not. Since L-alpha-methyl dopa and reserpine both deplete serotonin, and since both protect against anaphylactic shock, it is proposed that serotonin depletion is responsible for the protection. Enterochromaffin substance is depleted in anaphylactic shock. It is also depleted by reserpine and serotonin, both of which protect against anaphylactic shock when given prior to challenge with antigen. The amount of enterochromaffin substance seems to correlate with susceptibility to anaphylactic shock. The behavior of animals undergoing anaphylactic shock and the effect of shock on body temperature is similar to the effects on behavior and temperature of treatment with reserpine, which is known to release serotonin. The effect of monoamine oxidase inhibition on animals undergoing anaphylactic shock is also similar to the effect of monoamine oxidase inhibition on animals given reserpine. These results are consistent with the views that the release of serotonin is causally related to anaphylactic shock in mice and that serotonin is accumulated in the chromogenic material of the enterochromaffin cell.

Entities:  

Keywords:  ALLERGY/experimental; RESERPINE/pharmacology; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1962        PMID: 13898067      PMCID: PMC2137491          DOI: 10.1084/jem.115.2.367

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  In vitro anaphylaxis in the sensitized mouse uterus.

Authors:  M A FINK; M V ROTHLAUF
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

2.  A concept for a role of serotonin and norepinephrine as chemical mediators in the brain.

Authors:  B B BRODIE; P A SHORE
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

3.  Biochemical findings relating to the action of serotonin.

Authors:  S UDENFRIEND; H WEISSBACH; D F BOGDANSKI
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

4.  Anaphylaxis in the mouse: possible relation of the Schultz-Dale reaction to serotonin release.

Authors:  M A FINK
Journal:  Proc Soc Exp Biol Med       Date:  1956 Aug-Sep

5.  The release of 5-hydroxytryptamine by histamine liberators.

Authors:  B K BHATTACHARYA; G P LEWIS
Journal:  Br J Pharmacol Chemother       Date:  1956-06

6.  Some quantitative aspects of passive anaphylaxis in pertussis-vaccinated mice.

Authors:  M PITTMAN; F G GERMUTH
Journal:  Proc Soc Exp Biol Med       Date:  1954-11

7.  Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.

Authors:  T L SOURKES
Journal:  Arch Biochem Biophys       Date:  1954-08       Impact factor: 4.013

8.  The 5-hydroxytryptamine shock in the guinea-pig.

Authors:  H HERXHEIMER
Journal:  J Physiol       Date:  1955-06-28       Impact factor: 5.182

9.  Anaphylactic shock in the mouse vaccinated with Hemophilus pertussis. III. Antigens. antibody and passive transfer studies.

Authors:  S MALKIEL; B J HARGIS; S M FEINBERG
Journal:  J Immunol       Date:  1953-11       Impact factor: 5.422

10.  Mammalian enterochromaffin cells as the source of serotonin (5-hydroxytryptamine).

Authors:  R BARTER; A G E PEARSE
Journal:  J Pathol Bacteriol       Date:  1955 Jan-Apr
View more
  15 in total

1.  The effect of serotonin on pepsin inhibition by duodenal fat.

Authors:  M F Wazna; T Stein; L Wise
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

Review 2.  Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis.

Authors:  J Munoz; R K Bergman
Journal:  Bacteriol Rev       Date:  1968-06

3.  The role of the complement system in the pathogenesis of acute pulmonary oedema produced by nephrotoxic serum in rats.

Authors:  W D da Silva; M N Vieira; C R Diniz
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

4.  Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE.

Authors:  F Braga; I Mota
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

5.  Enterochromaffin cells and 5-hydroxytryptamine content of the colon of mice.

Authors:  G C Schofield; A K Ho; J M Southwell
Journal:  J Anat       Date:  1967-09       Impact factor: 2.610

6.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  Accumulation of platelets in the lung and liver and their degranulation following antigen-challenge in sensitized mice.

Authors:  Atsushi Yoshida; Mami Ohba; Xia Wu; Takashi Sasano; Masanori Nakamura; Yasuo Endo
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

8.  On the nature of the chemical mediators involved in anaphylactic reactions in mice.

Authors:  B N HALPERN; T NEVEU; S SPECTOR
Journal:  Br J Pharmacol Chemother       Date:  1963-06

9.  Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor.

Authors:  M D Gershon; L L Ross
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

10.  Location of sites of 5-hydroxytryptamine storage and metabolism by radioautography.

Authors:  M D Gershon; L L Ross
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.